➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Colorcon
Harvard Business School
Moodys
Johnson and Johnson

Last Updated: October 26, 2021

DrugPatentWatch Database Preview

Litigation Details for JAZZ PHARMACEUTICALS, INC. v. MALLINCKRODT PLC (D.N.J. 2018)


Email this page to a colleague

« Back to Dashboard

JAZZ PHARMACEUTICALS, INC. v. MALLINCKRODT PLC (D.N.J. 2018)

Docket ⤷  Free Forever Trial Date Filed 2018-01-01
Court District Court, D. New Jersey Date Terminated 2018-06-15
Cause 35:145 Patent Infringement Assigned To Esther Salas
Jury Demand None Referred To Joseph A. Dickson
Parties MALLINCKRODT PLC
Patents 6,045,501; 6,315,720; 6,561,977; 6,755,784; 6,780,889; 7,262,219; 7,668,730; 7,765,106; 7,765,107; 7,851,506; 7,895,059; 8,263,650; 8,324,275; 8,457,988; 8,589,182; 8,731,963; 8,772,306; 8,859,619; 8,952,062; 9,050,302; 9,486,426
Attorneys WILLIAM C. BATON
Firms Saul Ewing Arnstein & Lehr LLP
Link to Docket External link to docket
Small Molecule Drugs cited in JAZZ PHARMACEUTICALS, INC. v. MALLINCKRODT PLC
The small molecule drugs covered by the patents cited in this case are ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , and ⤷  Free Forever Trial .

Details for JAZZ PHARMACEUTICALS, INC. v. MALLINCKRODT PLC (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-01-01 1 those for nonnal drugs are imposed on the 6,045,501 A 4/2000 Elsayed et al. … 6,045,501 A 4/2000 Elsayed et al. … 6,045,501 A 4/2000 Elsayed et a!. AND …Shorewood, MN 6,045,501 A 4/2000 Elsayed et a!. … 6,045,501 A 4/2000 Elsayed et al. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Dow
Harvard Business School
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.